Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo

2015833 citationsJournal Article

Authors

Good health and well-being

Published in: Leukemia

Volume 30, Issue 2, pp. 492-500

Field-Weighted Citation Impact: 23.28